News from alere inc

Jul 14, 2014, 08:30 ET

New Alere™ q Point-of-Care Early Infant Diagnosis Test Prototype Accurately Detects HIV in Infants with High Sensitivity and Specificity in Primary Health Clinics in Mozambique

Alere Inc. (NYSE: ALR) today announced the publication of a study demonstrating the viability of accurate and rapid HIV screening among infants at...

Jul 01, 2014, 07:00 ET

Alere Announces Management Transition

 Alere Inc. (NYSE: ALR), a global leader in empowering individuals to take greater control of their health at home by connecting innovative...

Jun 18, 2014, 11:30 ET

Alere Opts Not to Pursue Initial Public Offering by BBI Diagnostics Group plc

 Alere Inc. (NYSE: ALR) today announced that it has elected not to proceed at this time with its previously announced plans to pursue an...

Jun 16, 2014, 08:30 ET

Alere Receives FDA Clearance for Alere™ i Influenza A and B Test

 Alere Inc. (NYSE: ALR), a leading global provider of point-of-care rapid diagnostic and health information solutions, today announced that it...

Jun 05, 2014, 14:00 ET

Alere Inc. Secures Important Permissions for Previously Announced Transaction Involving BBI Diagnostics Group plc

 Alere Inc. (NYSE: ALR) (the "Company") announced that it has received the requisite consents for its consent solicitations commenced on May...

May 22, 2014, 16:30 ET

Alere to Attend Upcoming Healthcare Conferences

Alere Inc. (NYSE: ALR), a global leader in empowering individuals to take greater control of their health at home by connecting innovative...

May 21, 2014, 17:30 ET

Alere Inc. Announces Commencement of Consent Solicitation Related to its 7.250% Senior Notes due 2018, 8.625% Senior Subordinated Notes due 2018 and 6.500% Senior Subordinated Notes due 2020.

Alere Inc. (NYSE: ALR) (the "Company") announced today that it has commenced a consent solicitation relating to its 7.250% Senior Notes due 2018...

May 15, 2014, 18:08 ET

Alere Inc. Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock

Alere Inc. (NYSE: ALR), a global leader in empowering individuals to take greater control of their health at home by connecting innovative...

May 06, 2014, 08:30 ET

Alere Initiates Voluntary URGENT PRODUCT RECALL of Alere INRatio®2 PT/INR Professional Test Strips

Alere Inc. (NYSE: ALR) has initiated a voluntary Class 1 recall in the U.S. of the Alere INRatio2 PT/INR Professional Test Strips (PN 99008G2)....

May 05, 2014, 08:30 ET

Alere Announces Separation of Chief Executive Officer and Chairman Roles and Review of Strategy

As part of its ongoing review and enhancement of its corporate governance policies, Alere Inc. (NYSE: ALR), a global leader in empowering...

Apr 29, 2014, 07:54 ET

Alere Inc. Announces Plan For Initial Public Offering By BBI Diagnostics Group plc

 Alere Inc. (NYSE: ALR) today announced plans to pursue an initial public offering in the United Kingdom of the ordinary shares of BBI...

Apr 29, 2014, 07:30 ET

Alere Inc. Announces First Quarter 2014 Results

 Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics...

Apr 25, 2014, 08:15 ET

Alere and Malaria No More Provide One Million Rapid Malaria Tests to Children in Zambia

 Alere Inc. (NYSE: ALR), a global leader in empowering individuals to take greater control of their health at home by connecting innovative...

Apr 22, 2014, 08:00 ET

Alere Inc. Schedules Conference Call for 8:30 a.m. ET April 29, 2014 to Discuss First Quarter 2014 Results

 Alere Inc. (NYSE:ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics...

Mar 24, 2014, 09:12 ET

Weekly Coagulation Self-testing among Warfarin Patients Significantly Improves Outcomes, According to Study Published in the American Journal of Managed Care

 Alere Inc. (NYSE: ALR) today announced the publication of the largest-ever study of warfarin patient self-testing, which demonstrated that...

Mar 04, 2014, 16:30 ET

Coagulation Home Testing Improves Outcomes among Atrial Fibrillation Patients on Warfarin Therapy and Enhances Clinical Efficiency, According to New Study

 Alere Inc. (NYSE: ALR), a global leader in empowering individuals to take greater control of their health at home by connecting innovative...

Mar 03, 2014, 19:33 ET

Alere Inc. Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock

 Alere Inc. (NYSE: ALR), a global leader in empowering individuals to take greater control of their health at home by connecting innovative...

Feb 24, 2014, 16:30 ET

Alere to Attend Upcoming Financial Conferences

Alere Inc. (NYSE: ALR), the world's leading provider of point-of-care rapid diagnostic and health information solutions, announced today that it...

Feb 19, 2014, 08:30 ET
The Alere(TM) MobilLink and INRatio2(R) PT/INR Monitor are "Connected Health" technologies that enable warfarin patients to test at home and deliver actionable data across the continuum of care.    (PRNewsFoto/Alere Inc.)

Alere to Showcase its Connected Health Technologies at HIMSS 2014

Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health through the merger of rapid diagnostics and health...

Feb 06, 2014, 07:30 ET

Alere Inc. Announces Fourth Quarter 2013 Results

 Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
ReportBuyer
Investor-Edge